Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about NVO

Recent news which mentions NVO

...

19 20 21 22 23 24 25 26 27

...

Why Viking Therapeutics Stock Rocked the Market Today

September 11, 2024

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $5,700 Today

September 11, 2024

Ozempic Maker Novo Nordisk Touts Encouraging Data From New Obesity Pill Showing Double Weight Loss Compared To Wegovy

September 11, 2024

Is Hims & Hers Health the Next Teladoc?

September 11, 2024

Novo Nordisk Reports Positive Results Of Weight-Loss Drug Liraglutide For Children As Young As 6, Eyes FDA And EMA Approval

September 11, 2024

Evaluating Novo Nordisk: Insights From 8 Financial Analysts

September 09, 2024

Billionaires Are Buying Viking Therapeutics Stock Left and Right. Should You Follow Their Lead?

September 07, 2024

What the Options Market Tells Us About Novo Nordisk

September 06, 2024

Goldman Sachs Shifts Stance On Novartis, Cites Lack Of Near-Term Catalysts

September 05, 2024

Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern

September 05, 2024

Battle Over Compounded Weight-Loss Medications - Sustainability and Regulation

September 05, 2024

Novo Nordisk Unusual Options Activity

September 05, 2024

Eli Lilly Just Made Zepbound Even More Appealing. Here's What Smart Investors Need to Know.

September 05, 2024

Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors?

September 05, 2024

Ascendis Pharma Faces Challenges With Skytrofa And Yorvipath Pricing: Analysts Weigh In

September 04, 2024

BioAge Labs Files For $100M IPO, Becomes The New Entrant In Obesity Drugs Race

September 04, 2024

EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity

September 04, 2024

Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs

September 03, 2024

10 Health Care Stocks With Whale Alerts In Today's Session

September 03, 2024

Eli Lilly Launches Discounted Mounjaro And Zepbound As Fight Against Compounded Imitations Escalates Amid Ongoing FDA Shortage Status Debate

September 02, 2024

Ozempic: Unexpected Anti-Aging Miracle Drug? Researchers Reveal Surprising Potential

August 31, 2024

3 No-Brainer Stocks to Buy in September

August 31, 2024

These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right Now

August 31, 2024

Judge's Early Ruling May Shape Outcome In Ozempic, Wegovy Lawsuits

August 30, 2024

Novo Nordisk Touts Encouraging Wegovy Data To Lower Risk Of Severe Complications In Heart Failure Patients

August 30, 2024

This New Finding About Ozempic and Wegovy Could Hurt Novo Nordisk's Stock

August 30, 2024

Is Eli Lilly Stock a No-Brainer Buy After the Company's Brilliant Zepbound Move?

August 29, 2024

Eli Lilly Is The Nvidia Of Weight Loss And GLP-1 Space, Says Roundhill Investments CEO, Emphasizes Market Leadership And Growth Potential Of Zepbound Maker

August 28, 2024

Looking At Novo Nordisk's Recent Unusual Options Activity

August 27, 2024

Ozempic Could Have a Terrible Side Effect. Is Novo Nordisk in Trouble?

August 27, 2024

...

19 20 21 22 23 24 25 26 27

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.